Daniel Yetman - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Daniel Yetman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Daniel Yetman
Verified
Writer, Freelance
Beats
FMCGs, Marketing Social Affairs, SustainabilityNews, Politics & more... Grocery, Retail
gaming, staffing
Content
By Daniel Yetman| Healthline Verified Semaglutide is a prescription medication used to treat type 2 diabetes. It may also help people with overweight or obesity lose weight, and it may help reduce fat buildup in the liver. Semaglutide falls into a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. These medications are most often prescribed to help manage type 2 diabetes.
By Daniel Yetman| Healthline Verified Semaglutide is a generic medication. Its brand names are approved for the treatment of type 2 diabetes and obesity. Compounded semaglutide is not FDA-approved, could come with risks, and may lead to adverse effects. In the United States, semaglutide isn’t available as a generic drug. It’s sold with a prescription under the following brand names:Compounding involves mixing or altering drug ingredients to create a medication for a specific need.
By Daniel Yetman| Healthline Verified Overall colon cancer rates in the United States have declined steadily over the last 30 years. But rates of colon cancer in young adults have risen dramatically during this period for unknown reasons. Colon or rectal cancer that develops in people under age 50 is often referred to as early-onset colorectal cancer. Rates of early-onset colorectal cancer in the United States have nearly doubled since the early 1990s and similar trends have been observed in many other countries.
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States